Literature DB >> 18275872

Multidetector row CT angiography in the evaluation of the hepatic artery and its anatomical variants.

L Saba1, G Mallarini.   

Abstract

A detailed study of the hepatic arteries is mandatory for several pathological conditions affecting the liver. Multidetector-row CT angiography (MDCTA), using fast patient imaging and thin collimation, generates near-isotropic voxels, producing excellent image quality and detail. In particular pre-surgical planning for patients undergoing hepatic surgery (tumour resection, transplantation) or selective chemotherapy infusion, requires a complete detailed assessment of hepatic vessel anatomy. The purpose of this article is to review the normal hepatic artery anatomy and its variants according to the Michels Classification, describing the post-processing techniques that can be employed to achieve the best results.

Entities:  

Mesh:

Year:  2007        PMID: 18275872     DOI: 10.1016/j.crad.2007.05.023

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  4 in total

1.  "Supraportal" right posterior hepatic artery: an anatomic trap in hepatobiliary and transplant surgery.

Authors:  Yuichiro Yoshioka; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Masato Nagino
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

2.  Anatomic variations of arterial liver vascularization: an analysis by using MDCTA.

Authors:  Luca Saba; Giorgio Mallarini
Journal:  Surg Radiol Anat       Date:  2011-01-20       Impact factor: 1.246

3.  Common hepatic artery arising from the aorta - demonstration with multidetector CT angiography and its clinical importance.

Authors:  Mustafa Koplay; Mecit Kantarci
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

4.  Non-enhanced T1-weighted liver vessel imaging at 7 Tesla.

Authors:  Anja Fischer; Oliver Kraff; Stefan Maderwald; Karsten Beiderwellen; Mark E Ladd; Michael Forsting; Thomas C Lauenstein; Lale Umutlu
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.